Journals

Haemophilia is a rare, monogenic disease that occurs from a single gene mutation and can have debilitating effects on the individual. With two subtypes, this inherited condition is currently treated with lifelong coagulation factor replacement therapy but is an ideal candidate for gene therapy management…

Welcome to the latest supplement of EMJ Gastroenterology. This publication brings you the latest insights and novel findings from the 17th Congress of the European Crohn’s and Colitis Organisation (ECCO), alongside highlights and hot topics in the field.

In an interview conducted by EMJ, leading experts from the field of nephrology and renal medicine discussed the high mortality rates in patients on long-term haemodialysis (HD), despite the recent developments in treatment.

Key learnings from a satellite symposium at the 9th Psoriasis: From Gene to Clinic Congress are summarised in an infographic exploring evolving understanding of IL-23 pathway inhibition in the treatment of psoriasis and psoriatic arthritis (PsA).

Identifying the genomic alterations in non-small cell lung cancer (NSCLC) can allow healthcare professionals to make the most suitable treatment decisions for patients.

Exposure to the sun’s radiation can be harmful to the skin, and the degree of the damage caused is dependent on factors such as the…

Expert discussion on the evolving role of immunotherapy in extensive-stage small cell lung cancer (ES-SCLC) from symposium sessions at the virtual 2020 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer are reviewed in this article. Masahiro Tsuboi, National Cancer Centre Hospital East, Tokyo, Japan, chaired and opened the session by exploring the role of immuno-oncology in the management of unresectable Stage III non-small cell lung cancer (NSCLC).

EXPERT discussion from a satellite symposium presented at the European Hematology Association (EHA) Virtual Congress 2021 focused on myelodysplastic syndrome (MDS), a heterogeneous group of myeloid malignancies characterised by ineffective haematopoiesis, progressive bone marrow failure, and increased risk of acute myeloid leukaemia evolution.